Literature DB >> 25264445

Creating musculoskeletal programs for culturally diverse, underserved communities: a community-based participatory research survey.

Sandra Goldsmith1, Dana Friedman2, Roberta Horton3, Mavis Seehaus3, Laura Robbins2.   

Abstract

BACKGROUND: Arthritis and other musculoskeletal diseases are the most prevalent health conditions in the USA, causing enormous financial and social burdens, especially in underserved communities. Targeted care and prevention programs are urgently needed. QUESTIONS/PURPOSES: Within an overall goal of revealing health disparities, the questionnaire explored (1) the use of and access to healthcare, (2) the factors affecting quality of life, and (3) the levels of provider-patient communication.
METHODS: A New York City musculoskeletal hospital conducted a community health needs survey among its diverse ethnic/racial communities. A 39-item questionnaire was administered online, by mail, and in person (in English, Spanish, and Chinese). Answers were analyzed in terms of sociodemographics, to define health disparities within a total sample and two subsamples.
RESULTS: In the total sample, respondents were 60% White, 16% Black, 14% Hispanic/Latino, and 11% Asian, mostly female, and aged 50 to 79. More than 17% of the total sample indicated they could not access a healthcare provider when needed. Poor nutrition and lack of physical activity were large areas of concern, as were falls and poor self-reported health status. Nearly all respondents said they took steps to communicate with their healthcare providers. Dramatic health disparities were found between Whites and non-Whites (e.g., non-Whites were most likely to rate their health poorly, consider their diet fair or poor, lack health insurance, and be unable to access a healthcare provider).
CONCLUSION: The findings are being used to further refine, develop, and expand the hospital's community programs, especially for culturally diverse and underserved communities.

Entities:  

Keywords:  arthritis; community health needs survey; culturally diverse; health disparities; musculoskeletal health

Year:  2014        PMID: 25264445      PMCID: PMC4171440          DOI: 10.1007/s11420-014-9413-9

Source DB:  PubMed          Journal:  HSS J        ISSN: 1556-3316


  8 in total

1.  Projections of US prevalence of arthritis and associated activity limitations.

Authors:  Jennifer M Hootman; Charles G Helmick
Journal:  Arthritis Rheum       Date:  2006-01

2.  National and state medical expenditures and lost earnings attributable to arthritis and other rheumatic conditions--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-01-12       Impact factor: 17.586

3.  An estimate of the worldwide prevalence and disability associated with osteoporotic fractures.

Authors:  O Johnell; J A Kanis
Journal:  Osteoporos Int       Date:  2006-09-16       Impact factor: 4.507

4.  Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time.

Authors:  G S Alarcón; J Calvo-Alén; G McGwin; A G Uribe; S M A Toloza; J M Roseman; M Fernández; B J Fessler; L M Vilá; C Ahn; F K Tan; J D Reveille
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

5.  Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation --- United States, 2007-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-10-08       Impact factor: 17.586

6.  The costs of musculoskeletal disease: health needs assessment and health economics.

Authors:  Deborah P Lubeck
Journal:  Best Pract Res Clin Rheumatol       Date:  2003-06       Impact factor: 4.098

7.  The challenge of patient adherence.

Authors:  Leslie R Martin; Summer L Williams; Kelly B Haskard; M Robin Dimatteo
Journal:  Ther Clin Risk Manag       Date:  2005-09       Impact factor: 2.423

8.  Physical activity reduces the risk of fragility fracture.

Authors:  Harri Sievänen; Pekka Kannus
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.